We've found
20,707
archived clinical trials in
Gastrointestinal
We've found
20,707
archived clinical trials in
Gastrointestinal
Sirolimus for Eosinophil-Associated Gastrointestinal Disorders
Updated: 5/31/2017
A Phase 1, Open-Label Study of Sirolimus in Eosinophil-Associated Gastrointestinal Disorders
Status: Enrolling
Updated: 5/31/2017
Sirolimus for Eosinophil-Associated Gastrointestinal Disorders
Updated: 5/31/2017
A Phase 1, Open-Label Study of Sirolimus in Eosinophil-Associated Gastrointestinal Disorders
Status: Enrolling
Updated: 5/31/2017
Click here to add this to my saved trials
Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)
Updated: 5/31/2017
A Phase Ib/II, Open-label Study of LJM716 in Combination With BYL719 Compared to Taxane or Irinotecan in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)
Status: Enrolling
Updated: 5/31/2017
Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)
Updated: 5/31/2017
A Phase Ib/II, Open-label Study of LJM716 in Combination With BYL719 Compared to Taxane or Irinotecan in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)
Status: Enrolling
Updated: 5/31/2017
Click here to add this to my saved trials
Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)
Updated: 5/31/2017
A Phase Ib/II, Open-label Study of LJM716 in Combination With BYL719 Compared to Taxane or Irinotecan in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)
Status: Enrolling
Updated: 5/31/2017
Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)
Updated: 5/31/2017
A Phase Ib/II, Open-label Study of LJM716 in Combination With BYL719 Compared to Taxane or Irinotecan in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)
Status: Enrolling
Updated: 5/31/2017
Click here to add this to my saved trials
Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)
Updated: 5/31/2017
A Phase Ib/II, Open-label Study of LJM716 in Combination With BYL719 Compared to Taxane or Irinotecan in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)
Status: Enrolling
Updated: 5/31/2017
Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)
Updated: 5/31/2017
A Phase Ib/II, Open-label Study of LJM716 in Combination With BYL719 Compared to Taxane or Irinotecan in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)
Status: Enrolling
Updated: 5/31/2017
Click here to add this to my saved trials
Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)
Updated: 5/31/2017
A Phase Ib/II, Open-label Study of LJM716 in Combination With BYL719 Compared to Taxane or Irinotecan in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)
Status: Enrolling
Updated: 5/31/2017
Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)
Updated: 5/31/2017
A Phase Ib/II, Open-label Study of LJM716 in Combination With BYL719 Compared to Taxane or Irinotecan in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)
Status: Enrolling
Updated: 5/31/2017
Click here to add this to my saved trials
Safety & Prevention Outcomes Study
Updated: 5/31/2017
A Brief Prescription Opioid Overdose Intervention in an Emergency Department
Status: Enrolling
Updated: 5/31/2017
Safety & Prevention Outcomes Study
Updated: 5/31/2017
A Brief Prescription Opioid Overdose Intervention in an Emergency Department
Status: Enrolling
Updated: 5/31/2017
Click here to add this to my saved trials
Parasitic Infections of the Gastrointestinal Tract
Updated: 6/1/2017
Study of Patients With Parasitic Infections of the Gastrointestinal Tract
Status: Enrolling
Updated: 6/1/2017
Parasitic Infections of the Gastrointestinal Tract
Updated: 6/1/2017
Study of Patients With Parasitic Infections of the Gastrointestinal Tract
Status: Enrolling
Updated: 6/1/2017
Click here to add this to my saved trials
A Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects
Updated: 6/7/2017
An Open-Label Parallel-Group Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects
Status: Enrolling
Updated: 6/7/2017
A Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects
Updated: 6/7/2017
An Open-Label Parallel-Group Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
A Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects
Updated: 6/7/2017
An Open-Label Parallel-Group Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects
Status: Enrolling
Updated: 6/7/2017
A Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects
Updated: 6/7/2017
An Open-Label Parallel-Group Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
A Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects
Updated: 6/7/2017
An Open-Label Parallel-Group Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects
Status: Enrolling
Updated: 6/7/2017
A Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects
Updated: 6/7/2017
An Open-Label Parallel-Group Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
Gram Negative Bacteremia, Risk Factors for Failure of Therapy
Updated: 6/8/2017
Gram Negative Bacteremia, Risk Factors for Failure of Therapy
Status: Enrolling
Updated: 6/8/2017
Gram Negative Bacteremia, Risk Factors for Failure of Therapy
Updated: 6/8/2017
Gram Negative Bacteremia, Risk Factors for Failure of Therapy
Status: Enrolling
Updated: 6/8/2017
Click here to add this to my saved trials
A Study To Describe The Effect Of Impaired Hepatic Function Of The Pharmacokinetics Of Palbociclib
Updated: 6/8/2017
A Phase 1, Open-label, Single Dose, Parallel-cohort Study To Evaluate The Pharmacokinetics Of Palbociclib (Pd-0332991) In Subjects With Impaired Hepatic Function
Status: Enrolling
Updated: 6/8/2017
A Study To Describe The Effect Of Impaired Hepatic Function Of The Pharmacokinetics Of Palbociclib
Updated: 6/8/2017
A Phase 1, Open-label, Single Dose, Parallel-cohort Study To Evaluate The Pharmacokinetics Of Palbociclib (Pd-0332991) In Subjects With Impaired Hepatic Function
Status: Enrolling
Updated: 6/8/2017
Click here to add this to my saved trials
A Study To Describe The Effect Of Impaired Hepatic Function Of The Pharmacokinetics Of Palbociclib
Updated: 6/8/2017
A Phase 1, Open-label, Single Dose, Parallel-cohort Study To Evaluate The Pharmacokinetics Of Palbociclib (Pd-0332991) In Subjects With Impaired Hepatic Function
Status: Enrolling
Updated: 6/8/2017
A Study To Describe The Effect Of Impaired Hepatic Function Of The Pharmacokinetics Of Palbociclib
Updated: 6/8/2017
A Phase 1, Open-label, Single Dose, Parallel-cohort Study To Evaluate The Pharmacokinetics Of Palbociclib (Pd-0332991) In Subjects With Impaired Hepatic Function
Status: Enrolling
Updated: 6/8/2017
Click here to add this to my saved trials
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
Updated: 6/14/2017
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
Status: Enrolling
Updated: 6/14/2017
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
Updated: 6/14/2017
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
Status: Enrolling
Updated: 6/14/2017
Click here to add this to my saved trials
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
Updated: 6/14/2017
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
Status: Enrolling
Updated: 6/14/2017
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
Updated: 6/14/2017
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
Status: Enrolling
Updated: 6/14/2017
Click here to add this to my saved trials
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
Updated: 6/14/2017
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
Status: Enrolling
Updated: 6/14/2017
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
Updated: 6/14/2017
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
Status: Enrolling
Updated: 6/14/2017
Click here to add this to my saved trials
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
Updated: 6/14/2017
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
Status: Enrolling
Updated: 6/14/2017
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
Updated: 6/14/2017
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
Status: Enrolling
Updated: 6/14/2017
Click here to add this to my saved trials
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
Updated: 6/14/2017
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
Status: Enrolling
Updated: 6/14/2017
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
Updated: 6/14/2017
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
Status: Enrolling
Updated: 6/14/2017
Click here to add this to my saved trials
Predictors of Unsuccessful Endoscopic Mucosal Resection of Complex Colon Polyps
Updated: 6/15/2017
Predictors of Unsuccessful Endoscopic Mucosal Resection of Complex Colon Polyps: "You Can Look But You Can't Touch"
Status: Enrolling
Updated: 6/15/2017
Predictors of Unsuccessful Endoscopic Mucosal Resection of Complex Colon Polyps
Updated: 6/15/2017
Predictors of Unsuccessful Endoscopic Mucosal Resection of Complex Colon Polyps: "You Can Look But You Can't Touch"
Status: Enrolling
Updated: 6/15/2017
Click here to add this to my saved trials
Predictors of Unsuccessful Endoscopic Mucosal Resection of Complex Colon Polyps
Updated: 6/15/2017
Predictors of Unsuccessful Endoscopic Mucosal Resection of Complex Colon Polyps: "You Can Look But You Can't Touch"
Status: Enrolling
Updated: 6/15/2017
Predictors of Unsuccessful Endoscopic Mucosal Resection of Complex Colon Polyps
Updated: 6/15/2017
Predictors of Unsuccessful Endoscopic Mucosal Resection of Complex Colon Polyps: "You Can Look But You Can't Touch"
Status: Enrolling
Updated: 6/15/2017
Click here to add this to my saved trials
Predictors of Unsuccessful Endoscopic Mucosal Resection of Complex Colon Polyps
Updated: 6/15/2017
Predictors of Unsuccessful Endoscopic Mucosal Resection of Complex Colon Polyps: "You Can Look But You Can't Touch"
Status: Enrolling
Updated: 6/15/2017
Predictors of Unsuccessful Endoscopic Mucosal Resection of Complex Colon Polyps
Updated: 6/15/2017
Predictors of Unsuccessful Endoscopic Mucosal Resection of Complex Colon Polyps: "You Can Look But You Can't Touch"
Status: Enrolling
Updated: 6/15/2017
Click here to add this to my saved trials
Predictors of Unsuccessful Endoscopic Mucosal Resection of Complex Colon Polyps
Updated: 6/15/2017
Predictors of Unsuccessful Endoscopic Mucosal Resection of Complex Colon Polyps: "You Can Look But You Can't Touch"
Status: Enrolling
Updated: 6/15/2017
Predictors of Unsuccessful Endoscopic Mucosal Resection of Complex Colon Polyps
Updated: 6/15/2017
Predictors of Unsuccessful Endoscopic Mucosal Resection of Complex Colon Polyps: "You Can Look But You Can't Touch"
Status: Enrolling
Updated: 6/15/2017
Click here to add this to my saved trials
Simultaneous Integrated Boost (SIB) in Esophageal Cancer
Updated: 6/19/2017
Phase I/II Study of Evaluating the Safety and Efficacy of Using a Simultaneous Integrated Boost for Dose Escalation in Patients With Esophageal Cancer
Status: Enrolling
Updated: 6/19/2017
Simultaneous Integrated Boost (SIB) in Esophageal Cancer
Updated: 6/19/2017
Phase I/II Study of Evaluating the Safety and Efficacy of Using a Simultaneous Integrated Boost for Dose Escalation in Patients With Esophageal Cancer
Status: Enrolling
Updated: 6/19/2017
Click here to add this to my saved trials
GSK962040 Drug-drug Interaction Study With Ketoconazole
Updated: 6/19/2017
An Open-label, Randomized, Single Sequence, Two Period Study to Assess the Effect of Repeat Oral Dosing of Ketoconazole on the Pharmacokinetics of a Single Oral Dose of GSK962040 in Healthy Volunteers
Status: Enrolling
Updated: 6/19/2017
GSK962040 Drug-drug Interaction Study With Ketoconazole
Updated: 6/19/2017
An Open-label, Randomized, Single Sequence, Two Period Study to Assess the Effect of Repeat Oral Dosing of Ketoconazole on the Pharmacokinetics of a Single Oral Dose of GSK962040 in Healthy Volunteers
Status: Enrolling
Updated: 6/19/2017
Click here to add this to my saved trials
Safety of ON 01910.Na and Irinotecan or ON 01910.Na and Oxaliplatin in Patients With Hepatoma
Updated: 6/22/2017
A Phase 1 Dose-Escalation Study of the Safety and Clinical Effects of ON 01910.Na in Combination With Either Irinotecan or Oxaliplatin in Patients With Hepatoma and Other Advanced Solid Tumors
Status: Enrolling
Updated: 6/22/2017
Safety of ON 01910.Na and Irinotecan or ON 01910.Na and Oxaliplatin in Patients With Hepatoma
Updated: 6/22/2017
A Phase 1 Dose-Escalation Study of the Safety and Clinical Effects of ON 01910.Na in Combination With Either Irinotecan or Oxaliplatin in Patients With Hepatoma and Other Advanced Solid Tumors
Status: Enrolling
Updated: 6/22/2017
Click here to add this to my saved trials
NEOX® CORD 1K vs Standard of Care in Non-healing Diabetic Foot Ulcers
Updated: 6/26/2017
A Multi-center, Randomized, Parallel, Crossover Design Study of Non-healing Diabetic Foot Ulcers, Treated With Cryopreserved, Umbilical Cord Allograft (NEOX® CORD 1K) Versus Standard of Care That Are Followed for 12 Weeks
Status: Enrolling
Updated: 6/26/2017
NEOX® CORD 1K vs Standard of Care in Non-healing Diabetic Foot Ulcers
Updated: 6/26/2017
A Multi-center, Randomized, Parallel, Crossover Design Study of Non-healing Diabetic Foot Ulcers, Treated With Cryopreserved, Umbilical Cord Allograft (NEOX® CORD 1K) Versus Standard of Care That Are Followed for 12 Weeks
Status: Enrolling
Updated: 6/26/2017
Click here to add this to my saved trials
NEOX® CORD 1K vs Standard of Care in Non-healing Diabetic Foot Ulcers
Updated: 6/26/2017
A Multi-center, Randomized, Parallel, Crossover Design Study of Non-healing Diabetic Foot Ulcers, Treated With Cryopreserved, Umbilical Cord Allograft (NEOX® CORD 1K) Versus Standard of Care That Are Followed for 12 Weeks
Status: Enrolling
Updated: 6/26/2017
NEOX® CORD 1K vs Standard of Care in Non-healing Diabetic Foot Ulcers
Updated: 6/26/2017
A Multi-center, Randomized, Parallel, Crossover Design Study of Non-healing Diabetic Foot Ulcers, Treated With Cryopreserved, Umbilical Cord Allograft (NEOX® CORD 1K) Versus Standard of Care That Are Followed for 12 Weeks
Status: Enrolling
Updated: 6/26/2017
Click here to add this to my saved trials
NEOX® CORD 1K vs Standard of Care in Non-healing Diabetic Foot Ulcers
Updated: 6/26/2017
A Multi-center, Randomized, Parallel, Crossover Design Study of Non-healing Diabetic Foot Ulcers, Treated With Cryopreserved, Umbilical Cord Allograft (NEOX® CORD 1K) Versus Standard of Care That Are Followed for 12 Weeks
Status: Enrolling
Updated: 6/26/2017
NEOX® CORD 1K vs Standard of Care in Non-healing Diabetic Foot Ulcers
Updated: 6/26/2017
A Multi-center, Randomized, Parallel, Crossover Design Study of Non-healing Diabetic Foot Ulcers, Treated With Cryopreserved, Umbilical Cord Allograft (NEOX® CORD 1K) Versus Standard of Care That Are Followed for 12 Weeks
Status: Enrolling
Updated: 6/26/2017
Click here to add this to my saved trials
Study Comparing Rifaximin With Xifaxan 200mg in Traveler's Diarrhea
Updated: 6/26/2017
A Randomized, Double-Blind, Parallel, Multicenter, Bioequivalence Study Comparing Rifaximin 200-mg Tablets With Xifaxan® 200-mg Tablets and With Placebo in the Treatment of Traveler's Diarrhea
Status: Enrolling
Updated: 6/26/2017
Study Comparing Rifaximin With Xifaxan 200mg in Traveler's Diarrhea
Updated: 6/26/2017
A Randomized, Double-Blind, Parallel, Multicenter, Bioequivalence Study Comparing Rifaximin 200-mg Tablets With Xifaxan® 200-mg Tablets and With Placebo in the Treatment of Traveler's Diarrhea
Status: Enrolling
Updated: 6/26/2017
Click here to add this to my saved trials
Prevention of Parastomal Hernia by Mesh Placement
Updated: 6/27/2017
A Randomized Study of the Utility of Composite Mesh Placement to Prevent Parastomal Hernia in Patients Undergoing Urinary Diversion With Ileal Conduit
Status: Enrolling
Updated: 6/27/2017
Prevention of Parastomal Hernia by Mesh Placement
Updated: 6/27/2017
A Randomized Study of the Utility of Composite Mesh Placement to Prevent Parastomal Hernia in Patients Undergoing Urinary Diversion With Ileal Conduit
Status: Enrolling
Updated: 6/27/2017
Click here to add this to my saved trials
Neurocognitive Effects of Opiate Agonist Treatment
Updated: 7/5/2017
Neurocognitive Effects of Opiate Agonist Treatment
Status: Enrolling
Updated: 7/5/2017
Neurocognitive Effects of Opiate Agonist Treatment
Updated: 7/5/2017
Neurocognitive Effects of Opiate Agonist Treatment
Status: Enrolling
Updated: 7/5/2017
Click here to add this to my saved trials
Neurocognitive Effects of Opiate Agonist Treatment
Updated: 7/5/2017
Neurocognitive Effects of Opiate Agonist Treatment
Status: Enrolling
Updated: 7/5/2017
Neurocognitive Effects of Opiate Agonist Treatment
Updated: 7/5/2017
Neurocognitive Effects of Opiate Agonist Treatment
Status: Enrolling
Updated: 7/5/2017
Click here to add this to my saved trials
Insulin Resistance in Nonalcoholic Fatty Liver Disease: A Case Control Study
Updated: 7/10/2017
Insulin Resistance in Nonalcoholic Fatty Liver Disease: A Case Control Study
Status: Enrolling
Updated: 7/10/2017
Insulin Resistance in Nonalcoholic Fatty Liver Disease: A Case Control Study
Updated: 7/10/2017
Insulin Resistance in Nonalcoholic Fatty Liver Disease: A Case Control Study
Status: Enrolling
Updated: 7/10/2017
Click here to add this to my saved trials
Neuromuscular Electrical Stimulation (NMES) for Dysphagia in Neonates
Updated: 7/17/2017
Randomized Treatment of Neuromuscular Electrical Stimulation (NMES) for Dysphagia in Neonates
Status: Enrolling
Updated: 7/17/2017
Neuromuscular Electrical Stimulation (NMES) for Dysphagia in Neonates
Updated: 7/17/2017
Randomized Treatment of Neuromuscular Electrical Stimulation (NMES) for Dysphagia in Neonates
Status: Enrolling
Updated: 7/17/2017
Click here to add this to my saved trials
Clotrimazole Enemas for Pouchitis in Children and Adults
Updated: 7/18/2017
Clotrimazole Enemas for Pouchitis in Children and Adults
Status: Enrolling
Updated: 7/18/2017
Clotrimazole Enemas for Pouchitis in Children and Adults
Updated: 7/18/2017
Clotrimazole Enemas for Pouchitis in Children and Adults
Status: Enrolling
Updated: 7/18/2017
Click here to add this to my saved trials
Self-Management Assistance for Recommended Treatment (SMART) Portal
Updated: 7/18/2017
Self-Management Assistance for Recommended Treatment (SMART) Portal
Status: Enrolling
Updated: 7/18/2017
Self-Management Assistance for Recommended Treatment (SMART) Portal
Updated: 7/18/2017
Self-Management Assistance for Recommended Treatment (SMART) Portal
Status: Enrolling
Updated: 7/18/2017
Click here to add this to my saved trials
Self-Management Assistance for Recommended Treatment (SMART) Portal
Updated: 7/18/2017
Self-Management Assistance for Recommended Treatment (SMART) Portal
Status: Enrolling
Updated: 7/18/2017
Self-Management Assistance for Recommended Treatment (SMART) Portal
Updated: 7/18/2017
Self-Management Assistance for Recommended Treatment (SMART) Portal
Status: Enrolling
Updated: 7/18/2017
Click here to add this to my saved trials
Individualized Infiximab Dosing-Proof of Concept Study
Updated: 7/18/2017
Individualized Infiximab Dosing-Proof of Concept Study
Status: Enrolling
Updated: 7/18/2017
Individualized Infiximab Dosing-Proof of Concept Study
Updated: 7/18/2017
Individualized Infiximab Dosing-Proof of Concept Study
Status: Enrolling
Updated: 7/18/2017
Click here to add this to my saved trials
The Role of Small Bowel Ultrasound in Initiation of Infliximab in Crohn's Disease Patients
Updated: 7/18/2017
The Role of Small Bowel Ultrasound After Ileocolic Resection or When Starting Infliximab in Crohn's Disease Patients
Status: Enrolling
Updated: 7/18/2017
The Role of Small Bowel Ultrasound in Initiation of Infliximab in Crohn's Disease Patients
Updated: 7/18/2017
The Role of Small Bowel Ultrasound After Ileocolic Resection or When Starting Infliximab in Crohn's Disease Patients
Status: Enrolling
Updated: 7/18/2017
Click here to add this to my saved trials
Vitamin D Levels Following Topical Application of Vitamin D Ointment
Updated: 7/19/2017
Vitamin D Levels in Subjects With Vitamin D Deficiency Following Topical Application of Three Doses of Vitamin D Ointment - A Proof of Concept Study
Status: Enrolling
Updated: 7/19/2017
Vitamin D Levels Following Topical Application of Vitamin D Ointment
Updated: 7/19/2017
Vitamin D Levels in Subjects With Vitamin D Deficiency Following Topical Application of Three Doses of Vitamin D Ointment - A Proof of Concept Study
Status: Enrolling
Updated: 7/19/2017
Click here to add this to my saved trials
Two Doses Mesalazine Granules Versus Placebo for the Prevention of Recurrence of Diverticulitis
Updated: 7/20/2017
Double-blind, Dose-response, Randomised, Placebo-controlled, Parallel Group, Multi-centre Phase III Clinical Study on the Efficacy and Tolerability of Mesalazine Granules vs. Placebo for the Prevention of Recurrence of Diverticulitis
Status: Enrolling
Updated: 7/20/2017
Two Doses Mesalazine Granules Versus Placebo for the Prevention of Recurrence of Diverticulitis
Updated: 7/20/2017
Double-blind, Dose-response, Randomised, Placebo-controlled, Parallel Group, Multi-centre Phase III Clinical Study on the Efficacy and Tolerability of Mesalazine Granules vs. Placebo for the Prevention of Recurrence of Diverticulitis
Status: Enrolling
Updated: 7/20/2017
Click here to add this to my saved trials
A Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult Subjects
Updated: 7/24/2017
A Single Centre, Single Sequence, Open-Label, Repeat-Dose Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult Subjects
Status: Enrolling
Updated: 7/24/2017
A Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult Subjects
Updated: 7/24/2017
A Single Centre, Single Sequence, Open-Label, Repeat-Dose Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult Subjects
Status: Enrolling
Updated: 7/24/2017
Click here to add this to my saved trials
An Open-Label Study Investigating MK-8931 in Participants With Mild and Moderate Hepatic Insufficiency (MK-8931-016)
Updated: 7/27/2017
A Two-Part, Open-Label Study to Investigate the Single-Dose Pharmacokinetics of MK-8931 When Administered to Subjects With Mild and Moderate Hepatic Insufficiency
Status: Enrolling
Updated: 7/27/2017
An Open-Label Study Investigating MK-8931 in Participants With Mild and Moderate Hepatic Insufficiency (MK-8931-016)
Updated: 7/27/2017
A Two-Part, Open-Label Study to Investigate the Single-Dose Pharmacokinetics of MK-8931 When Administered to Subjects With Mild and Moderate Hepatic Insufficiency
Status: Enrolling
Updated: 7/27/2017
Click here to add this to my saved trials
An Open-Label Study Investigating MK-8931 in Participants With Mild and Moderate Hepatic Insufficiency (MK-8931-016)
Updated: 7/27/2017
A Two-Part, Open-Label Study to Investigate the Single-Dose Pharmacokinetics of MK-8931 When Administered to Subjects With Mild and Moderate Hepatic Insufficiency
Status: Enrolling
Updated: 7/27/2017
An Open-Label Study Investigating MK-8931 in Participants With Mild and Moderate Hepatic Insufficiency (MK-8931-016)
Updated: 7/27/2017
A Two-Part, Open-Label Study to Investigate the Single-Dose Pharmacokinetics of MK-8931 When Administered to Subjects With Mild and Moderate Hepatic Insufficiency
Status: Enrolling
Updated: 7/27/2017
Click here to add this to my saved trials
Gene Methylation in the Diagnosis of Barrett's Esophagus: Identification of Candidate Diagnostic Markers
Updated: 8/1/2017
Utility of Aberrant Gene Methylation in the Diagnosis of Barrett's Esophagus: Identification of Candidate Diagnostic Markers
Status: Enrolling
Updated: 8/1/2017
Gene Methylation in the Diagnosis of Barrett's Esophagus: Identification of Candidate Diagnostic Markers
Updated: 8/1/2017
Utility of Aberrant Gene Methylation in the Diagnosis of Barrett's Esophagus: Identification of Candidate Diagnostic Markers
Status: Enrolling
Updated: 8/1/2017
Click here to add this to my saved trials
The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy.
Updated: 8/3/2017
The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy
Status: Enrolling
Updated: 8/3/2017
The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy.
Updated: 8/3/2017
The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy
Status: Enrolling
Updated: 8/3/2017
Click here to add this to my saved trials
Incisional Hernia and Adhesion-Related Bowel Obstruction
Updated: 8/3/2017
Incisional Hernia and Adhesion-Related Bowel Obstruction After Open and Laparoscopic Colorectal Surgery: A Prospective Cohort Study
Status: Enrolling
Updated: 8/3/2017
Incisional Hernia and Adhesion-Related Bowel Obstruction
Updated: 8/3/2017
Incisional Hernia and Adhesion-Related Bowel Obstruction After Open and Laparoscopic Colorectal Surgery: A Prospective Cohort Study
Status: Enrolling
Updated: 8/3/2017
Click here to add this to my saved trials
Switching From Efavirenz to Atazanavir/ Ritonavir in HIV-infected Subjects With Good Virologic Suppression
Updated: 8/10/2017
A Randomized Study to Evaluate the Effect of Switching From Efavirenz to Atazanavir/ Ritonavir on Lipoatrophy and Mitochondrial Dysfunction in HIV-infected Subjects With Good Virologic Suppression
Status: Enrolling
Updated: 8/10/2017
Switching From Efavirenz to Atazanavir/ Ritonavir in HIV-infected Subjects With Good Virologic Suppression
Updated: 8/10/2017
A Randomized Study to Evaluate the Effect of Switching From Efavirenz to Atazanavir/ Ritonavir on Lipoatrophy and Mitochondrial Dysfunction in HIV-infected Subjects With Good Virologic Suppression
Status: Enrolling
Updated: 8/10/2017
Click here to add this to my saved trials
Domperidone in Refractory Gastroparesis
Updated: 8/17/2017
Domperidone in Refractory Gastroparesis
Status: Enrolling
Updated: 8/17/2017
Domperidone in Refractory Gastroparesis
Updated: 8/17/2017
Domperidone in Refractory Gastroparesis
Status: Enrolling
Updated: 8/17/2017
Click here to add this to my saved trials
Nicotine Gum Recovery After Colorectal Surgery
Updated: 8/21/2017
Does Nicotine Gum Enhance Bowel Recovery After Colorectal Surgery?
Status: Enrolling
Updated: 8/21/2017
Nicotine Gum Recovery After Colorectal Surgery
Updated: 8/21/2017
Does Nicotine Gum Enhance Bowel Recovery After Colorectal Surgery?
Status: Enrolling
Updated: 8/21/2017
Click here to add this to my saved trials